Blood-Brain Barrier Imaging and Therapeutic Potentials
Authors:
- James FinkJFJames Fink
- Yoshimi AnzaiYAYoshimi Anzai
- Kenneth R. MaravillaKMKenneth R. Maravilla
- 1 April 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Topics in Magnetic Resonance Imaging
- Vol. 17 (2) , 107-116
Abstract
Much work has been done in the last several decades to improve the understanding of the molecular composition of the blood-brain barrier (BBB). Advances in magnetic resonance imaging have resulted in development of dynamic magnetic resonance imaging techniques to quantify permeability measurements across the brain endothelium. This review describes the basic anatomical and biochemical concepts of a BBB and the various techniques for magnetic resonance measurement of BBB permeability. To date, BBB permeability data have been shown to be useful in preoperative brain tumor grading and potentially also in determining the effectiveness of selective types of therapy. Explorative studies are evaluating new strategies for safe and effective altering of the BBB permeability to improve local drug delivery into brain tumors. As new antiangiogenesis drugs become available, BBB permeability imaging may also become critical as a surrogate angiogenesis marker to monitor tumor response to these agents. Finally, BBB permeability data may also prove useful in future applications to guide therapy in other nontumoral disease processes such as acute cerebral ischemia and inflammatory processes such as multiple sclerosis.Keywords
This publication has 48 references indexed in Scilit:
- Statins reduce human blood–brain barrier permeability and restrict leukocyte migration: Relevance to multiple sclerosisAnnals of Neurology, 2006
- Hyperbaric Oxygen Reduces Blood–Brain Barrier Damage and Edema After Transient Focal Cerebral IschemiaStroke, 2005
- Enhanced chemotherapy delivery by intraarterial infusion and blood‐brain barrier disruption in malignant brain tumorsCancer, 2005
- Vascular Endothelial Growth Factor Antagonist Reduces Brain Edema Formation and Venous InfarctionStroke, 2005
- The blood–brain barrier: an overviewNeurobiology of Disease, 2004
- MRI for assessing antivascular cancer treatmentsBritish Journal of Radiology, 2003
- A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant gliomaNeuro-Oncology, 2003
- Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumorsJournal of Neurosurgery, 1999
- Blood brain barrier permeability in multiple sclerosis using labelled DTPA with PET, CT and MRI.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971